Become a Monthly Donor Become one of our community of dedicated supporters by becoming a monthly donor to TAG. Your recurring contribution provides steady support for critical programs, groundbreaking research, and advocacy efforts to combat HIV, hepatitis C, and tuberculosis…
Treatment Action Group (TAG) is issuing an urgent call to protect the integrity of biomedical research and public health.
Treatment Action Group (TAG) decries the vicious and inchoate attacks on HHS since the advent of the new administration, which have escalated significantly over the past week.
The nomination of Dr. Jay Bhattacharya for Director of the United States National Institutes of Health (NIH) continues the pattern of un- and under-qualified nominees put forward by the current administration.
Treatment Action Group (TAG) is disgusted and appalled by the new presidential administration’s flagrant attack on science.
The new U.S. presidential administration has issued several executive orders, which use pseudo-scientific claims to deny the existence of transgender and non-binary people.
Treatment Action Group (TAG) is appalled by President Donald Trump’s executive order Monday signaling the United States will be withdrawing from the World Health Organization (WHO).
Treatment Action Group’s (TAG) most important fundraising event of the year is the Research in Action Awards, which honor the best and brightest activists, researchers, leaders, and scientists whose work has been integral in ending HIV, tuberculosis (TB), and hepatitis C (HCV).
Treatment Action Group (TAG) supports the World Health Organization (WHO) in declaring the renewed outbreak of mpox a public health emergency of international concern.
Treatment Action Group (TAG) elected three new members to its Board of Directors in May 2024. Board President Ivy Kwan Arce said, "TAG is reinvigorating its Board in alignment with our vision, mission, and values.